№ lp_1_2_23344
File format: docx
Character count: 1579
File size: 392 KB
This document provides detailed information on the MMR-containing vaccines and their administration guidelines according to the Australian and Victorian immunisation schedules.
Year:
2024
Region / City:
Victoria, Australia
Topic:
Immunisation
Document Type:
Official Information
Author:
Department of Health, State of Victoria
Target Audience:
Healthcare professionals, parents, and individuals requiring immunisation information
Period of Validity:
Not specified
Approval Date:
August 2024
Date of Changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / city:
London, UK
Topic:
Immunization, MMR vaccine
Document type:
Informational guide
Organization / institution:
NHS
Author:
Public Health England
Target audience:
Parents, caregivers
Effective period:
Ongoing
Approval date:
N/A
Date of updates:
N/A
Year:
2022
Region:
London, United Kingdom
Topic:
Childhood immunisation
Vaccine:
MMR (measles, mumps, rubella)
Type of document:
Public health communication toolkit
Health system:
NHS
Target population:
Parents and carers of children aged 1–5 years
Vaccination schedule:
1 year (first dose), 3 years and 4 months (second dose)
Key threshold:
95% coverage for herd immunity
Related organisations:
NHS, UK medicines and vaccines regulator, Oxford University Vaccine Knowledge Project
Format:
Overview with key messages, resources, Q&A, and sample communication content
Year:
2025
Region / city:
Global
Topic:
Vaccine Policy, Maternal Health, Group B Streptococcus
Document type:
WHO Guidance
Institution:
World Health Organization (WHO)
Author:
WHO ECVP
Target audience:
Policymakers, Vaccine Developers, Public Health Authorities
Period of validity:
Ongoing
Approval date:
March 11, 2025
Date of changes:
Not specified
Year:
2024
Region / city:
Global
Topic:
COVID-19 Vaccines
Document type:
Report
Author:
World Health Organization (WHO)
Target audience:
Health professionals, regulatory authorities
Approval date:
16 January 2024
Modification date:
N/A
Contextual description:
A report listing COVID-19 vaccines evaluated under the WHO EUL/PQ process, including details on manufacturers, vaccine types, shelf lives, and approval dates.
Year:
2026
Jurisdiction:
Victoria, Australia
Document type:
Report form
Subject:
Vaccine cold chain breach reporting
Issuing authority:
Department of Health, Victorian Government
Program:
Immunisation Program
Applicable vaccines:
Government funded vaccines and immunisation products
Target users:
Immunisation providers
Scope:
Cold chain breach events excluding delivery incidents
Temperature range reference:
+2°C to +8°C
Reporting method:
Email submission to Immunisation Program
Publication date:
January 2026
Publisher:
State of Victoria, Australia
Copyright holder:
Department of Health, Victoria
Note:
Year
Region / City:
Alabama
Theme:
Vaccine management, immunization program
Document Type:
Vaccine management plan
Organization / Institution:
Alabama Department of Public Health (ADPH)
Author:
Alabama Department of Public Health (ADPH)
Target Audience:
VFC providers, immunization staff
Effective Period:
Ongoing
Year:
2023
Region / City:
Massachusetts
Topic:
Meningococcal disease, Vaccination requirements
Document type:
Health advisory
Institution:
Massachusetts Department of Public Health
Author:
Massachusetts Department of Public Health
Target audience:
College and residential school students, Parents and legal guardians
Period of validity:
Ongoing
Approval date:
Not specified
Amendment date:
Not specified
Year:
2025
Region / city:
Victoria, Australia
Subject:
Immunisation, Vaccines
Document type:
Health guideline
Organ / institution:
Department of Health and Human Services, Victorian Government
Author:
Victorian Government
Target audience:
Healthcare professionals, general public, parents, caregivers
Period of validity:
Until 2025
Approval date:
July 2025
Date of amendments:
Not specified
Year:
2023
Region / city:
Australia
Topic:
COVID-19 vaccines
Document type:
Clinical guidance
Organization / institution:
Australian Technical Advisory Group on Immunisation (ATAGI)
Author:
Australian Technical Advisory Group on Immunisation (ATAGI)
Target audience:
Healthcare professionals, general public
Period of validity:
Ongoing
Approval date:
October 2023
Date of changes:
Multiple updates since February 2021
Year:
2025
Region / City:
Northern Ireland
Topic:
COVID-19 vaccination, mRNA vaccines
Document Type:
Protocol
Organization / Institution:
Strategic Planning and Performance Group (SPPG), Public Health Agency (PHA)
Author:
Dr. Louise Herron, Mrs. Deirdre Ward, Mrs. Kathryn Turner
Target Audience:
Healthcare professionals administering COVID-19 mRNA vaccines
Period of Validity:
3 April 2025 to 30 June 2025
Approval Date:
3 April 2025
Note:
Change History
Version 1.0:
New national protocol for COVID-19 vaccines (adults) - 5 April 2024
Version 2.0:
Updated to reflect change in vaccine antigenic content - 16 September 2024
Version 3.0:
Updated eligibility criteria for Spring 2025 - 6 March 2025
Year:
2025
Region / City:
Wisconsin
Theme:
Public Health, Vaccination Programs
Document Type:
Provider Agreement
Organization:
Department of Health Services, Division of Public Health
Author:
Department of Health Services
Target Audience:
Health Care Providers, Medical Directors
Period of Validity:
Annual Enrollment
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2023
Region / City:
Europe
Topic:
Access to medicines, hormones, healthcare for trans and gender-diverse people
Document Type:
Analytical study
Organ / Institution:
United Nations Office of the High Commissioner for Human Rights
Author:
Transgender Europe (TGEU), ILGA-Europe
Target Audience:
Policymakers, Human Rights Advocates, Health Professionals
Period of validity:
N/A
Approval Date:
N/A
Date of changes:
N/A
Year:
2023
Region / city:
Australia
Topic:
HPV vaccination recommendations
Document type:
Advisory report
Organization / institution:
Australian Technical Advisory Group on Immunisation (ATAGI)
Author:
Australian Technical Advisory Group on Immunisation (ATAGI)
Target audience:
Healthcare professionals, policy makers, the general public
Validity period:
Ongoing
Approval date:
30 January 2023
Amendment date:
30 January 2023
Year:
2020
Region / city:
Global
Topic:
COVID-19, Clinical Trials, Remote Monitoring, Data Verification
Document Type:
Guide/Playbook
Organization:
European Medicines Agency (EMA)
Author:
Not specified
Target Audience:
Clinical Trial Monitors, Healthcare Professionals, Regulatory Agencies
Period of Action:
Ongoing during COVID-19 pandemic
Approval Date:
July 2020
Date of Changes:
Not specified
Live Attenuated Vaccines: Avoid Use In Those Who Are Clinically Immunosuppressed, Including Neonates
Year:
2016
Region / City:
Wales
Topic:
Vaccination, Immunosuppression
Document Type:
Medical/Health Advisory
Organization:
NHS Wales
Author:
Dr Chris Jones
Target Audience:
Healthcare professionals, General practitioners, Paediatricians, Oncologists, Rheumatologists, Immunologists, Nurses, Pharmacists, Medical Directors
Period of Validity:
Not specified
Approval Date:
4 May 2016
Modification Date:
Not specified
Contextual Description:
Medical advisory document warning healthcare professionals about the risks of live attenuated vaccines for immunosuppressed individuals, especially neonates and elderly patients.
Year:
2021
Region / City:
Global
Subject:
Procurement
Document Type:
Bidding Document
Organization:
The World Bank
Author:
The World Bank
Target Audience:
Bidders, Contractors, Procurement Officers
Period of Validity:
N/A
Approval Date:
June 2021
Date of Changes:
June 2021
Year:
2017
Sector:
Health
Goods covered:
Pharmaceuticals, Vaccines, Condoms
Document type:
Standard Procurement Document
Procurement stage:
Prequalification
Procurement method:
Request for Bids
Issuing organization:
World Bank
Applicable regulations:
Procurement Regulations for IPF Borrowers
Financing sources:
IBRD, IDA
Initial issue:
July 2016
Revision dates:
July 2016; January 2017; October 2017
Geographic applicability:
World Bank-financed projects
Legal framework reference:
Procurement Regulations for IPF Borrowers, July 2016 as amended
Intended users:
Borrowers and implementing agencies
Copyright status:
Copyrighted; non-commercial use only
Year:
2021
Organization:
3GPP
Meeting:
TSG-SA5 Meeting #140-e
Specification:
TS 28.541
Release:
Rel-17
Document type:
Change Request
CR number:
0634
Category:
F (correction)
Current version:
17.4.0
Work item code:
adNRM
Date:
2021-11-04
Source to WG:
Nokia; Nokia Shanghai Bell
Source to TSG:
S5
Affected area:
Core Network; Radio Access Network
Clauses affected:
D.4.3
Reason for change:
Wrong attribute listed in IOC NRCellRelation (nRFrequencyRef instead of nRFreqRelationRef)
Summary of change:
Correction of the attribute name in the OpenAPI definition of IOC NRCellRelation with editorial updates
Consequences if not approved:
Misalignment between stage 2 and stage 3
Related specification:
OpenAPI 3.0.1 NR NRM (nrNrm.yaml)
Year:
2025
Region / city:
Victoria, Australia
Subject:
Immunisation, Vaccines
Document type:
Health guideline
Organ / institution:
Department of Health and Human Services, Victorian Government
Author:
Victorian Government
Target audience:
Healthcare professionals, general public, parents, caregivers
Period of validity:
Until 2025
Approval date:
July 2025
Date of amendments:
Not specified
Year:
Date:
Note:
Region / City
Subject:
Violation Correction Order
Document Type:
Legal Order
Agency:
Local Health Authority
Author:
Local Health Authority
Target Audience:
Property Owners, Property Managers
Action Period:
Within noted timeframe on inspection report
Context:
A legal document ordering correction of health code violations on a residential property after inspection by the local health authority, including the right to request a hearing.